Issues related to funding for psychedelics research and psychedelic-assisted therapy
2026 · 1st Quarter (Jan 1 - Mar 31)
REASON FOR HOPE
Filed by DB3, LLC (FKA THE DASCHLE GROUP).
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2026
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- DB3, LLC (FKA THE DASCHLE GROUP)
- Client
- REASON FOR HOPE
- Filing UUID
- 04d017f7-10d1-4190-8639-ef6bdeb092b1
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Veterans mental health research & treatment
Freedom to Heal Act (H.R.6434/S.3346)
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.